Bellicum, Astellas Announce License Agreement for Cancer Target PSCA in Cell and Gene Therapy
December 11, 2015 at 04:15 AM EST
Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM) and Astellas Pharma Inc. (OTC: ALPMY) today announced that Agensys, ...